PARK THERAPEUTICS
Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of pain which is Phase III-ready. Development focused biotechnology company, whose goal is finding better solutions for pain patients.
PARK THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2020-01-01
Address:
Morristown, New Jersey, United States
Country:
United States
Website Url:
http://www.parktherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Wix
Official Site Inspections
http://www.parktherapeutics.com
- Host name: 81.224.148.132.host.secureserver.net
- IP address: 132.148.224.81
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Park Therapeutics"
Park Therapeutics - Crunchbase Company Profile
Organization. Park Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Park Therapeutics, a …See details»
Park Therapeutics - Owler
Park Therapeutics is a New Jersey-based pharmaceutical company that develops investigational drugs for the treatment of chronic pain... Read more. Founder & CEO. James Hackworth. CEO …See details»
Park Therapeutics 2025 Company Profile: Valuation, …
Park Therapeutics’s primary industry is Drug Discovery. Is Park Therapeutics a private or public company? Park Therapeutics is a Private company. What is Park Therapeutics’s current revenue? The current revenue for Park Therapeutics is …See details»
Tris Pharma® Announces Acquisition of Park Therapeutics – Pain …
MONMOUTH JUNCTION, NJ, April 29, 2021 / PRNewswire/ – Tris Pharma, Inc. (“Tris”), a specialty pharmaceutical company with a robust portfolio of approved products and a late …See details»
Park Therapeutics - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Park Therapeutics is a private …See details»
Park Therapeutics - Ownership and Business Overview - Mergr
Apr 29, 2021 Park Therapeutics is a life science company. Life Science M&A Summary in 2021 Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021 .See details»
Park Therapeutics - The Org
Park Therapeutics mission is to develop new treatments that revolutionize the management of pain, by bringing new drugs to the market that are safer and more effective with less addiction potential. Industries. Biotechnology. …See details»
Park Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Park Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news.See details»
PARK THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PARK THERAPEUTICS, INC. of Monmouth Junction, NJ. Get the latest business insights from Dun …See details»
Park Therapeutics (LKW7MCDM3GG5) - HigherGov
Park Therapeutics (UEI LKW7MCDM3GG5, CAGE 8TKS5) based in Monmouth Junction NJ federal contracts, grants, registrations, vehicles, partnerships, and analysis. Description. ... For …See details»
Park Therapeutics, Inc. - LinkedIn
Park Therapeutics, Inc. | 53 followers on LinkedIn. Development focused biotechnology company, whose goal is finding better solutions for pain patients.See details»
Tris Pharma® Announces Acquisition of Park Therapeutics - PR …
Apr 29, 2021 Tris Pharma® Announces Acquisition of Park Therapeutics - Pain Company with First-In-Class, Phase III-Ready New Chemical Entity (NCE) - Novel mechanism of action, …See details»
Park Therapeutics, Inc.:Company Profile & Technical …
Mar 9, 2023 Park Therapeutics, Inc. is headquartered in United States New Jersey. Park Therapeutics, Inc. was founded in 2020. Park Therapeutics, Inc. has a total of 36 patents . …See details»
Tris Pharma acquires Park Therapeutics - 2021-04-29 - Crunchbase
Apr 29, 2021 Acquired Organization: Park Therapeutics Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of pain which is …See details»
Park Therapeutics - Products, Competitors, Financials, Employees ...
About Park Therapeutics. Park Therapeutics focuses on developing new drugs for the treatment of pain. The companies goal is to help the increasing number of patients with pain and to help …See details»
Park Therapeutics, Inc. | Insights
Jun 8, 2023 Latest on Park Therapeutics, Inc. Already A Biomedtracker Subscriber? You have access to the full company record through your subscription. Go To Biomedtracker. Twitter feed RSS feed RSS feed. About Us Opens in new window; Meet the Team Opens in new window; RSS Feed Opens in new window;See details»
Park Therapeutics - Overview, News & Competitors - ZoomInfo
Park Therapeutics. Consumer Services · New Jersey, United States · <25 Employees. Park Therapeutics Inc is a company that operates in the Biotechnology industry. It employs 1-5 …See details»
Tris Pharma Announces Acquisition of Park Therapeutics - Pain …
MONMOUTH JUNCTION, N.J., April 29, 2021 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of approved products and a late …See details»
Tris Pharma® Acquires Park Therapeutics | American …
Apr 29, 2021 Tris Pharma, Inc., a specialty pharmaceutical company with a portfolio of approved products and a late-stage pipeline of product candidates for the treatment of Attention Deficit …See details»
James Hackworth, PHD - BIO Investor Forum | BIO
President, park therapeutics, inc. Morristown, New Jersey, United States Dr. Hackworth is a pharmaceutical executive with an extensive track record in licensing, M&A, and partnership transactions, particularly ones with a high degree of complexity, pharmaceutical commercialization and clinical development strategy and is an expert on the US pain market.See details»